Answers are grounded in this paper and cite their sources.
Patients with severe muscle spasticity are still one of the most complicated and resistant to therapies groups of neurorehabilitation patients.During the last several years of its application intrathecal baclofen therapy has become an effective method of treating spasticity which is resistant to other therapies and has a negative impact on patients' quality of life.Despite its wide acknowledgement some clarification is needed to confirm the actual need in this method for the current clinical practice as well as the development of general recommendations for treating these patients.There was a protocol of National Prospective Register for treating spastic states with intrathecal baclofen therapy in the Russian federation developed and there was an available electronic source created, which allows to organize the data on the therapy of patients with spasticity, analyze the therapy schemes used, evaluate the therapy outcomes and frequency of adverse events in a wide population.
No takes yet. Share an insight, caveat, or question.
Морозов et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: